AstraZeneca
Beyfortus Approved to Prevent RSV in Infants & Children
The FDA approved Beyfortus (for the prevention of RSV lower respiratory tract disease in newborns and infants born ...
JULY 18, 2023
FDA Approves Imfinzi for Advanced Bladder Cancer
Durvalumab is a human monoclonal antibody directed against programmed death ligand-1 (PD-L1), which blocks the ...
MAY 3, 2017
Osimertinib Scores in Post-Marketing Trial for NSCLC
Overall response rate is among the best reported for first-line therapy of EGFR-mutated NSCLC.
JULY 22, 2016
Load more